Health authorities in the United Arab Emirates have intensified efforts to address the rising trend of peptide use, warning against the risks associated with unregulated products and self-administered treatments promoted on social media. The Emirates Drug Establishment recently took regulatory action against 71 entities marketing unapproved peptides and referred 14 social media influencers to authorities for promoting such substances without proper oversight.

Medical professionals have expressed concern about the growing number of individuals obtaining peptides through online vendors and influencer recommendations, often bypassing medical consultation and necessary diagnostic testing. Experts caution that this practice can lead to adverse health effects, inappropriate treatment choices, and financial loss.

“Many people use peptides believing they are harmless because they are marketed as ‘natural’ or ‘anti-ageing,’ but these products often lack rigorous clinical testing and quality control,” said Dr. Yousef Said, medical director and diabetologist at Metabolic. He emphasized that peptides encompass a broad range of molecules with differing biological impacts, some approved for specific medical conditions, while others remain experimental and should not be promoted as proven therapies for ageing or wellness.

Endocrinologist Dr. Ismail Arslan of Metabolic added that a comprehensive medical assessment, including liver, kidney, and thyroid function tests, as well as blood sugar levels, is essential before considering peptide therapy. “Monitoring these baselines allows for evaluating treatment effects and minimizing risks,” he noted. Unsupervised peptide use can cause side effects such as fluid retention, blood sugar irregularities, and blood pressure changes, he warned. Additionally, sourcing products from unregulated suppliers raises concerns about counterfeit or contaminated substances, incorrect dosages, and improper storage.

The psychological factors behind the surge in peptide demand were highlighted by psychologist Hiba Badawi. She explained that influencers often communicate in emotionally resonant ways, fostering familiarity and trust that can overshadow medical advice. “People seek quick fixes for ageing and physical concerns, driven by fears of decline and a desire for social acceptance,” she said. Social media platforms reinforce associations between peptide use and confidence, happiness, or youthfulness, which may prompt individuals to overlook potential health risks. The fear of missing out on perceived benefits can further pressure people into trying unapproved treatments.

Pharmacist Mowaffak Alsadek pointed out that consumers face significant challenges verifying the authenticity of peptide products purchased online. Unlike medicines dispensed through licensed pharmacies, products from unofficial sources may be counterfeit, contaminated, or improperly handled. He urged consumers to be cautious of unusually low prices, sellers lacking licenses, and suspicious packaging. Individuals who have used such products are advised to discontinue use and seek medical evaluation if experiencing adverse effects.

Ultimately, medical professionals stress that decisions regarding peptide therapies should be grounded in evidence-based practices, individualized patient assessments, and regulated supply chains. As Dr. Said summarized, the key consideration is not simply whether a substance is labeled as a peptide but whether it represents an appropriate and safe treatment prescribed and monitored by qualified healthcare providers.